Filing Flows

Filing Flows › Alphatec Holdings (ATEC) › Recalls, complaints & regulation

Alphatec Holdings (ATEC): recalls and clinical trials

Alphatec Holdings (ATEC) beyond its filings: 3 recalls in the last 12 months (7 in five years, 0 Class I); 2 active clinical trials.

Latest recalls

Alphatec Holdings' latest quarter

Alphatec Holdings, Q3 2026: revenue $221M (+13% year over year), operating margin 1.5%, net loss $5.5M, operating cash flow $18.9M. The chart follows the revenue to costs, profit and cash.

Questions

Has Alphatec Holdings had any recalls?

7 recalls on file over five years from the FDA, CPSC and NHTSA; 3 in the last 12 months.

How many clinical trials does Alphatec Holdings have?

2 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.